Emily Dewar

Emily Dewar

Company: Merck & Co

Job title: Associate Principal Scientist

Seminars:

Improving Binding Capacity & Throughput of Therapeutic mRNA with Oligo dT (OdT) Immobilized Fibro Prototype Chromatography Media 11:30 am

 Evaluation of two commercially available OdT matrices and one prototype media for affinity chromatography of mRNA vaccine candidates Assessing OdT membrane for purification of mRNA vaccine candidates presented in recent manuscript Showcasing the impact of improved binding capacity and throughput afforded by novel OdT affinity chromatography media typeRead more

day: mRNA Purification Focus Day

Panel Discussion: Boosting Assay Development for Purification Processes to Accurately Measure & Characterize dsRNA to Improve Drug Substance Safety 12:00 pm

Understanding dsRNA impurity profiles and assessing the best standards by which to characterize it Optimizing current cell-based assays to assess immunogenicity with greater sensitivity evoked by dsRNA Adopting and selecting appropriate process controls to enhance purification assays for dsRNA characterizationRead more

day: mRNA Purification Focus Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.